Fuschia SERRE

Fonctions

  • Ingénieure de recherche

 

Contact

 

 

Rattachement

  • SANPSY - Equipe Addiction

 

Diplômes

 

  • 2012 - Doctorat en Psychologie, Université de Bordeaux
  • 2006 - Master 2 Recherche Neurosciences, Université Bordeaux

 

Thèmes de recherche

Addiction ; Craving ; Rechute ; EMA (Ecological Momentary Assessment) Recherche clinique en Psychiatrie.

Publications



Articles

2023

  1. Chapron, S-A.; Kervran, C.; Da Rosa, M.; Fournet, L.; Shmulewitz, D.; Hasin, D.; Denis, C.; Collombat, J.; Monsaingeon, M.; Fatseas, M.; Gatta-Cherifi, B.; Serre, F. et al. Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample. In Drug and Alcohol Dependence, 251: 110937, 2023. doi 
  2. Chirokoff, V.; Dupuy, M.; Abdallah, M.; Fatseas, M.; Serre, F.; Auriacombe, M.; Misdrahi, D.; Berthoz, S.; Swendsen, J.; Sullivan, E. V. and Chanraud, S. Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders. In Addiction Neuroscience, 9: 100138, 2023. doi 
  3. David, J-C.; Fonte, D.; Sutter-Dallay, A-L.; Auriacombe, M.; Serre, F.; Rascle, N. and Loyal, D. The stigma of smoking among women: A systematic review. In Social Science & Medicine, 340: 116491, 2023. doi 
  4. Dora, J.; Piccirillo, M.; Foster, K. T.; Arbeau, K.; Armeli, S.; Auriacombe, M.; Bartholow, B.; Beltz, A. M.; Blumenstock, S. M.; Bold, K.; Bonar, E. E.; Braitman, A. et al. The daily association between affect and alcohol use: A meta-analysis of individual participant data. In Psychological Bulletin, 149 (1-2): 1-24, 2023. doi 
  5. Gauld, C.; Baillet, E.; Micoulaud-Franchi, J-A.; Kervran, C.; Serre, F. and Auriacombe, M. The centrality of craving in network analysis of five substance use disorders. In Drug and Alcohol Dependence, 245: 109828, 2023. doi 
  6. Loyal, D.; Sutter, A.-L.; Auriacombe, M.; Serre, F. and Rascle, N. The Pregnant Smoker Stigma Scale - Self Stigma (P3S-SS): development and validation in pregnant smoking women in France. In Women & Health, 63 (7): 507-517, 2023. doi 
  7. Martin-Fernandez, J.; Perrin, S.; Stevens, N.; Moriceau, S.; Serre, F.; Auriacombe, M.; France, S. and Cambon, L. Realist evaluation of the impact, viability and transferability of an alcohol harm reduction support program based on mental health recovery: the vitae study: First results. In Population Medicine, 5 (Supplement), 2023. doi 
  8. Morawetz, C.; Berboth, S.; Chirokoff, V.; Chanraud, S.; Misdrahi, D.; Serre, F.; Auriacombe, M.; Fatseas, M. and Swendsen, J. Mood Variability, Craving, and Substance Use Disorders: From Intrinsic Brain Network Connectivity to Daily Life Experience. In Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 8 (9): 940-955, 2023. doi 
  9. Sanchez-Ortuno, M. M.; Pecune, F.; Coelho, J.; Micoulaud-Franchi, J. A.; Salles, N.; Auriacombe, M.; Serre, F.; Levavasseur, Y.; de Sevin, E.; Sagaspe, P. and Philip, P. Predictors of users' adherence to a fully automated digital intervention to manage insomnia complaints. In Journal of the American Medical Informatics Association, 2023. doi 
  10. Serre, F.; Moriceau, S.; Donnadieu, L.; Forcier, C.; Garnier, H.; Alexandre, J-M.; Dupuy, L.; Philip, P.; Levavasseur, Y.; de Sevin, E. and Auriacombe, M. The Craving-Manager smartphone app designed to diagnose substance use/addictive disorders, and manage craving and individual predictors of relapse: a study protocol for a multicenter randomized controlled trial. In Frontiers in Psychiatry, 14, 2023. doi 

2022

  1. Boudard, M.; Alexandre, J-M.; Kervran, C.; Jakubiec, L.; Shmulewitz, D.; Hasin, D.; Fournet, L.; Rassis, C.; Claverie, P.; Serre, F. and Auriacombe, M. Item Response Theory Analyses of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Criteria Adapted to Screen Use Disorder: Exploratory Survey. In Journal of Medical Internet Research, 24 (7): e31803, 2022. doi 
  2. Jakubiec, L.; Chirokoff, V.; Abdallah, M.; Sanz-Arigita, E.; Dupuy, M.; Swendsen, J.; Berthoz, S.; Gierski, F.; Guionnet, S.; Misdrahi, D.; Serre, F.; Auriacombe, M. et al. The Executive Functioning Paradox in Substance Use Disorders. In Biomedicines, 10 (11): 2728, 2022. doi 
  3. Lambert, L.; Serre, F.; Thirioux, B.; Jaafari, N. and Auriacombe, M. Clinical insight level predicts successful quit or control attempts during the first three months of outpatient addiction treatment. In Drug and Alcohol Dependence, 234: 109391, 2022. doi 
  4. Lambert, L.; Serre, F.; Thirioux, B.; Jaafari, N.; Roux, P.; Jauffret-Roustide, M.; Lalanne, L.; Daulouède, J-P. and Auriacombe, M. Link Between Perception of Treatment Need and Craving Reports in Addiction. In Frontiers in Psychiatry, 12, 2022. doi 
  5. Loyal, D.; Sutter, A-L.; Auriacombe, M.; Serre, F.; Calcagni, N. and Rascle, N. Stigma Attached to Smoking Pregnant Women: A Qualitative Insight in the General French Population. In Nicotine & Tobacco Research, 24 (2): 257-264, 2022. doi 
  6. Loyal, D.; Sutter, A-L.; Auriacombe, M.; Serre, F. and Rascle, N. The Pregnant Smoker Stigma Scale – Public Stigma (P3S-PS): development and validation in general French population. In Women & Health, 62 (2): 157-167, 2022. doi 
  7. Martin-Fernandez, J.; Stevens, N.; Moriceau, S.; Serre, F.; Blanc, H.; Latourte, E.; Auriacombe, M. and Cambon, L. Realist evaluation of the impact, viability and transferability of an alcohol harm reduction support programme based on mental health recovery: the Vitae study protocol. In BMJ Open, 12 (8): e065361, 2022. doi 
  8. Stevens, N.; Martin-Fernandez, J.; Moriceau, S.; Serre, F.; Auriacombe, M. and Cambon, L. Realist evaluation of three programmes aimed at reducing harm and risks associated with alcohol consumption in the Nouvelle Aquitaine region of France: the ECIAE study protocol. In BMJ Open, 12 (10): e057928, 2022. doi 

2021

  1. Auriacombe, M.; Fournet, L.; Dupuy, L.; Micoulaud-Franchi, J-A.; de Sevin, E.; Moriceau, S.; Baillet, E.; Alexandre, J-M.; Serre, F. and Philip, P. Effectiveness and Acceptance of a Smartphone-Based Virtual Agent Screening for Alcohol and Tobacco Problems and Associated Risk Factors During COVID-19 Pandemic in the General Population. In Frontiers in Psychiatry, 12, 2021. doi 
  2. Bahadoor, R.; Alexandre, J-M.; Fournet, L.; Gellé, T.; Serre, F. and Auriacombe, M. Inventory and Analysis of Controlled Trials of Mobile Phone Applications Targeting Substance Use Disorders: A Systematic Review. In Frontiers in Psychiatry, 12, 2021. doi 
  3. Dupuy, L.; de Sevin, E.; Bioulac, S.; Taillard, J.; Salles, N.; Serre, F.; Auriacombe, M.; Micoulaud-Franchi, J-a. and Philip, P. Efficacité d'une TCC contre l'insomnie dispensée par un agent virtuel : Résultats pendant et après le confinement du COVID-19. In Médecine du Sommeil, 18 (1): 26, 2021. doi 
  4. Dupuy, M.; Abdallah, M.; Swendsen, J.; N'Kaoua, B.; Chanraud, S.; Schweitzer, P.; Fatseas, M.; Serre, F.; Barse, E.; Auriacombe, M. and Misdrahi, D. Real-time cognitive performance and positive symptom expression in schizophrenia. In European Archives of Psychiatry and Clinical Neuroscience, 2021. doi 
  5. Kervran, C.; Shmulewitz, D.; Serre, F.; Denis, C.; Roux, P.; Jauffret-Roustide, M.; Lalanne, L.; Hasin, D. and Auriacombe, M. Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach. In Addictive Behaviors, 116: 106797, 2021. doi 
  6. Philip, P.; Dupuy, L.; Morin, C.; de Sevin, E.; Bioulac, S.; Taillard, J.; Serre, F.; Auriacombe, M. and Micoulaud-Franchi, J-A. Des agents virtuels sur smartphone pour faire face aux plaintes de sommeil pendant le confinement du COVID-19 : étude de faisabilité. In Médecine du Sommeil, 18 (1): 43, 2021. doi 

2020

  1. Kervran, C.; Shmulewitz, D.; Serre, F.; Stohl, M.; Denis, C.; Hasin, D. and Auriacombe, M. Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special?. In Drug and Alcohol Dependence, 212: 108036, 2020. doi 
  2. Philip, P.; Dupuy, L.; Auriacombe, M.; Serre, F.; de Sevin, E.; Sauteraud, A. and Micoulaud-Franchi, J-A. Trust and acceptance of a virtual psychiatric interview between embodied conversational agents and outpatients. In npj Digital Medicine, 3 (1): 2, 2020. doi 
  3. Philip, P.; Dupuy, L.; Morin, C. M.; de Sevin, E.; Bioulac, S.; Taillard, J.; Serre, F.; Auriacombe, M. and Micoulaud-Franchi, J-A. Smartphone-Based Virtual Agents to Help the General Population Concerned by Sleep Complaints During COVID-19 Confinement: A Feasibility Study (Preprint). In Journal of Medical Internet Research, 22 (12), 2020.
  4. Philip, P.; Dupuy, L.; Morin, C. M.; de Sevin, E.; Bioulac, S.; Taillard, J.; Serre, F.; Auriacombe, M. and Micoulaud-Franchi, J-A. Smartphone-Based Virtual Agents Can Help the General Population Concerned by Sleep Complaints: A Proof-of-Concept Study During COVID-19 Confinement. In SSRN Electronic Journal, 22 (12), 2020. doi 
  5. Philip, P.; Dupuy, L.; Morin, C. M.; de Sevin, E.; Bioulac, S.; Taillard, J.; Serre, F.; Auriacombe, M. and Micoulaud-Franchi, J-A. Smartphone-Based Virtual Agents to Help Individuals With Sleep Concerns During COVID-19 Confinement: Feasibility Study. In Journal of Medical Internet Research, 22 (12): e24268, 2020. doi 

2019

  1. Micoulaud Franchi, J.-A.; Schmitt, L.; Prebois, S.; Bensoussan, A.; Lasserre, M.; Haoui, R.; Bensoussan, M. and Gaudelus, B. Société médico-psychologique - Les nouveaux dispositifs de soins en psychiatrie. In French Journal of Psychiatry, 1: S73, 2019. doi 

2018

  1. Auriacombe, M.; Moriceau, S.; Serre, F.; Denis, C.; Micoulaud-Franchi, J-A.; de Sevin, E.; Bonhomme, E.; Bioulac, S.; Fatseas, M. and Philip, P. Development and validation of a virtual agent to screen tobacco and alcohol use disorders. In Drug and Alcohol Dependence, 193: 1-6, 2018. doi 
  2. Bouvard, A.; Dupuy, M.; Schweitzer, P.; Revranche, M.; Fatseas, M.; Serre, F.; Misdrahi, D.; Auriacombe, M. and Swendsen, J. Feasibility and validity of mobile cognitive testing in patients with substance use disorders and healthy controls. In The American Journal on Addictions, 27 (7): 553-556, 2018. doi 
  3. Dupuy, M.; Misdrahi, D.; N'Kaoua, B.; Tessier, A.; Bouvard, A.; Schweitzer, P.; Auriacombe, M.; Serre, F.; Fatseas, M. and Swendsen, J. Mobile cognitive testing in patients with schizophrenia: A controlled study of feasibility and validity. In Journal de Thérapie Comportementale et Cognitive, 28 (4): 204-213, 2018. doi 
  4. Fatseas, M.; Serre, F.; Swendsen, J. and Auriacombe, M. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study. In Drug and Alcohol Dependence, 187: 242-248, 2018. doi 
  5. Serre, F.; Fatseas, M.; Denis, C.; Swendsen, J. and Auriacombe, M. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances. In Addictive Behaviors, 83: 123-129, 2018. doi 

2017

  1. Denis, C. M.; da Rosa, M. A. C.; Serre, F.; Kervran, C.; Henry, M.; Cherifi, B.; Auriacombe, M. and Fatseas, M. Are DSM-5 criteria for sud transferable to food addiction? IRT analysis for alcohol, tobacco, cannabis, opiate and food addiction in a clinical sample. In Drug and Alcohol Dependence, 171: e52, 2017. doi 
  2. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. How psychiatric comorbidity and mood states influence craving and substance use in daily life? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin use disorders. In Drug and Alcohol Dependence, 171: e187, 2017. doi 

2016

  1. Auriacombe, M.; Debrabant, R.; Kervran, C.; Serre, F.; Taillard, J.; Philip, P.; Denis, C. and Fatséas, M. Addiction et troubles du sommeil : craving, rythmes circadiens. Une mise au point. In Médecine du Sommeil, 13 (3): 91-99, 2016. doi 
  2. Auriacombe, M; Serre, F and Fatseas, M Le craving : marqueur diagnostique et pronostique des addictions?. In Traité d'addictologie, 2016.
  3. Denis, C.; Fatséas, M.; Beltran, V.; Serre, F.; Alexandre, J-M.; Debrabant, R.; Daulouède, J-P. and Auriacombe, M. Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling. In Substance Abuse, 37 (1): 168-175, 2016. doi 
  4. Fatséas, M.; Hurmic, H.; Serre, F.; Debrabant, R.; Daulouède, J-P.; Denis, C. and Auriacombe, M. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions. In Psychiatry Research, 246: 656-662, 2016. doi 
  5. Vandaele, Y.; Cantin, L.; Serre, F.; Vouillac-Mendoza, C. and Ahmed, S. H. Choosing Under the Influence: A Drug-Specific Mechanism by Which the Setting Controls Drug Choices in Rats. In Neuropsychopharmacology, 41 (2): 646-657, 2016. doi 

2015

  1. Auriacombe, M.; Denis, C. M.; Rosa, M. A. C.; Collombat, J.; Serre, F.; Daulouede, J-P. and Fatseas, M. Validity of the eating section for the modified addiction severity index. In Drug and Alcohol Dependence, 156: e12, 2015. doi 
  2. Fatseas, M.; Collombat, J.; Rosa, M. A. C.; Denis, C. M.; Alexandre, J-M.; Debrabant, R.; Serre, F. and Auriacombe, M. Measuring “craving” in food addiction: Type, frequency, intensity. In Drug and Alcohol Dependence, 156: e66, 2015. doi 
  3. Fatseas, M; Hurmic, H.; Debrabant, R.; Serre, F and Auriacombe, M. Substance use patterns associated with adult ADHD in SUD treatment-seeking patients: Results from the aquitaine addiction cohort study. In Drug and Alcohol Dependence, 146: e274-e275, 2015. doi 
  4. Fatseas, M.; Serre, F.; Alexandre, J-M.; Debrabant, R.; Auriacombe, M. and Swendsen, J. Craving and substance use among patients with alcohol, tobacco, cannabis or heroin addiction: a comparison of substance- and person-specific cues. In Addiction, 110 (6): 1035-1042, 2015. doi 
  5. Hurmic, H.; Debrabant, R.; Kervran, C.; Serre, F.; Auriacombe, M. and Fatseas, M. ADHD and substance use disorders: Subtype and gender differences. In Drug and Alcohol Dependence, 156: e100-e101, 2015. doi 
  6. Hurmic, H.; Debrabant, R.; Serre, F.; Fatseas, M.; Alix, M. and Auriacombe, M. Frequency and intensity of craving among addicted patients during outpatient treatment. In Drug and Alcohol Dependence, 146: e145, 2015. doi 
  7. Kervran, C; Serre, F; Fatseas, M; Debrabant, R.; Trouba, C; Taillard, J; Philip, P and Auriacombe, M. Sleep quality in patients with SUD and behavioral addictions assessed by actigraphy: A prospective study. In Drug and Alcohol Dependence, 146: e156-e157, 2015. doi 
  8. Kervran, C.; Fatséas, M.; Serre, F.; Taillard, J.; Beltran, V.; Leboucher, J.; Debrabant, R.; Alexandre, J-M.; Daulouède, J-P.; Philip, P. and Auriacombe, M. Association between morningness/eveningness, addiction severity and psychiatric disorders among individuals with addictions. In Psychiatry Research, 229 (3): 1024-1030, 2015. doi 
  9. Rosa, M. A. C.; Collombat, J.; Denis, C. M.; Alexandre, J-M.; Serre, F.; Auriacombe, M. and Fatseas, M. Overlap between food addiction and DSM-5 eating disorders in a treatment seeking sample. In Drug and Alcohol Dependence, 156: e192, 2015. doi 
  10. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Does craving intensity influence cue exposure reports? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin use disorder. In Drug and Alcohol Dependence, 156: e201, 2015. doi 
  11. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Corrigendum to “Ecological momentary assessment in the investigation of craving and substance use in daily life: A systematic review” Drug and Alcohol Dependence 148 (2015) 1–20. In Drug and Alcohol Dependence, 154: 305-314, 2015. doi 
  12. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Ecological momentary assessment in the investigation of craving and substance use in daily life: A systematic review. In Drug and Alcohol Dependence, 148: 1-20, 2015. doi 

2014

  1. Auriacombe, M.; Denis, C. M.; Beltran, V.; Alexandre, J.; Debrabant, R.; Serre, F.; Daulouede, J-P. and Fatseas, M. 10-years outcome of methadone- and buprenorphine-maintained patients. Mortality, quality of life and substance use. In Drug and Alcohol Dependence, 140: e8, 2014. doi 
  2. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Does craving predict substance use for different substance use disorders? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin dependence. In Drug and Alcohol Dependence, 140: e202-e203, 2014. doi 
  3. Serre, F; Fatseas, M; Swendsen, J and Auriacombe, M Are sleep disturbances associated with craving intensity?: What is the influence of psychiatric comorbidity and type of substance on this relationship? A computerized ambulatory monitoring study in patients beginning treatment for addiction. In 76th College on Problems of Drug Dependence, 2014.
  4. Serre, F; Fatséas, M; Swendsen, J; Taillard, J; Philip, P and Auriacombe, M Relation entre problèmes de sommeil et envie de consommer (craving) chez des sujets dépendants en début de prise en charge pour leur addiction. In Medecine du sommeil, 11 (34), 2014.

2013

  1. Lenoir, M.; Cantin, L.; Vanhille, N.; Serre, F. and Ahmed, S. H Extended Heroin Access Increases Heroin Choices Over a Potent Nondrug Alternative. In Neuropsychopharmacology, 38 (7): 1209-1220, 2013. doi 

2012

  1. Fatseas, M.; Denis, C.; Serre, F.; Dubernet, J.; Daulouède, J-P. and Auriacombe, M. Change in HIV-HCV Risk-Taking Behavior and Seroprevalence Among Opiate Users Seeking Treatment Over an 11-year Period and Harm Reduction Policy. In AIDS and Behavior, 16 (7): 2082-2090, 2012. doi 
  2. Serre, F; Denis, C; Fatseas, M and Auriacombe, M Santé, travail et addiction. In Le Courrier des Addictions, 14: 22-23, 2012.
  3. Serre, F.; Fatseas, M.; Debrabant, R.; Alexandre, J-M.; Auriacombe, M. and Swendsen, J. Ecological momentary assessment in alcohol, tobacco, cannabis and opiate dependence: A comparison of feasibility and validity. In Drug and Alcohol Dependence, 126 (1-2): 118-123, 2012. doi 

Collections

2018

  1. Auriacombe, M.; Serre, F.; Denis, C. and Fatséas, M. Diagnosis of Addictions. In The Routledge Handbook of Philosophy and Science of Addiction, pages 132-144, Routledge, 1 [edition]. | New York : Routledge, 2018. | Series: Routledge handbooks in philosophy, 2018.

2016

  1. Denis, C.; Alexandre, J-M.; Serre, F.; Auriacombe, M. and Fatséas, M. 38. Outils d'évaluation pour les addictions. In Traité d'addictologie, 2016.

In Proceedings

2013

  1. Fatseas, M; Serre, F; Swendsen, J and Auriacombe, M Does cue type matter for Craving?: Comparison of substance-specific and person-specific cues using mobile technologies. In 75th College on Problems of Drug Dependence, 2013.
  2. Serre, F; Fatseas, M; M., S J and Auriacombe, M Does craving predict substance use for different substance use disorders?: Ecological Momentary Assessment in alcohol, tobacco, cannabis and heroin dependence. In 75th College on Problems of Drug Dependence, 2013.
  3. Swendsen, J; Serre, F; Fatseas, M and Auriacombe, M A systematic review of studies exploring craving, its moderators, and the link with substance use in daily life using Ecological Momentary Assessment (EMA). In 75th College on Problems of Drug Dependence, 2013.

2012

  1. Fatseas, M; Serre, F; Swendsen, J and Auriacombe, M Relationships between sleep disturbances and variations of craving in patients beginning treatment for addiction: a computerized ambulatory monitoring study. In 74th College on Problems of Drug Dependence, Palm Springs, California, 2012.
  2. Quintin, J; Serre, F; Fatseas, M; Auriacombe, S and Auriacombe, M Relationships between decision making, type of addiction, and addiction severity. In 74th College on Problems of Drug Dependence, Palm Springs, California, 2012.
  3. Serre, F; Swendsen, J; Fatseas, M and Auriacombe, M Feasibility and validity of Ecological Momentary Assessment in alcohol, tobacco, cannabis and opiates dependent patients. In 74th College on Problems of Drug Dependence, Palm Springs, California, 2012.

 

 

 

 

 

 


Université de Bordeaux CNRS

CNRS UMR 6033


Participez à une étude...

A noter

"Cannabis, comment expérimenter la législation encadrée ?"

Directeur

Pr. Marc Auriacombe

Directeur adjoint

J. Taillard

Administration :

Tel : +33 (0)5 57 82 01 73

Bureau Recherche Sommeil

Tel : +33 (0)5 57 82 01 82

Bureau Recherche Addiction

Tel : +33 (0)5 56 56 17 67

Adresse :

UMR 6033 SANPSY
CHU Pellegrin, Tripode
13ème étage, aile 3
Place Amélie- Raba-Léon
33076 Bordeaux cédex
France

logo SANPSY Accéder au laboratoire

Investissement d'Avenir Clinilabs Certified Site Clinilabs Certified Site